Drug
insulin glargine and lixisenatide
Marketed as SOLIQUA 100/33.
Generic name
insulin glargine and lixisenatide
Brand names
SOLIQUA 100/33
First FDA approval
2016-11-21
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA208673 | SOLIQUA 100/33 | 2016-11-21 | SANOFI-AVENTIS US |
Manufacturers
SANOFI-AVENTIS US
Frequently asked questions
When was insulin glargine and lixisenatide FDA approved?
Earliest FDA approval on record: 2016-11-21.
What brand names are sold as insulin glargine and lixisenatide?
SOLIQUA 100/33.
Sources
Appeal a insulin glargine and lixisenatide denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com